Información del producto
- 1-Pyrrolidineacetamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo-
- Amacetam
- N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
- N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide sulfate (1:1)
- N-[2-[Bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide
- Vinpotropil
Pramiracetam is a nootropic drug that is used to treat symptoms of dementia and other cognitive disorders. It has pharmacological effects on the brain by interacting with the fatty acid composition of cell membranes, which affects voltage-dependent calcium channels. Pramiracetam also increases cholinergic neurotransmission and increases energy metabolism in cells by increasing adenosine triphosphate (ATP) synthesis. This drug's pharmacokinetic properties include a high bioavailability, rapid absorption, and short half-life. Histological analysis of animals treated with pramiracetam has shown an increase in the size of neurons and synapses in the cerebral cortex, hippocampus, olfactory bulb, cerebellum, and hypothalamus.
Propiedades químicas
Consulta técnica sobre: 3D-FP35140 Pramiracetam
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
